Skip to main content

Cell and Myofibril Contractile Properties of hiPSC-Derived Cardiomyocytes from a Patient with a MYH7 Mutation Associated with Familial Cardiomyopathy

Pioner, Josè Manuel, Yang, Kai-Chun, Pabon, Lil, Racca, Alice Ward, Jeong, Mark Y., Childers, Christian I., Macadangdang, Jesse, Tesi, Chiara, Poggesi, Corrado, Kim, Deok-Ho, and others. (2015) Cell and Myofibril Contractile Properties of hiPSC-Derived Cardiomyocytes from a Patient with a MYH7 Mutation Associated with Familial Cardiomyopathy. In: Biophysical Journal. 108 (2). 201a. The Biophysical Society (doi:10.1016/j.bpj.2014.11.1110) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) (KAR id:53703)

The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided.
Official URL:
http://doi.org/10.1016/j.bpj.2014.11.1110

Abstract

Myosin heavy chain 7 (MYH7) mutations are associated with familial cardiomyopathies (FCM) and result in a high rate of sudden cardiac death. Human induced pluripotent stem cells derived cardiomyocytes (hiPSC-CMs) have recently shown promise as a model for studying FCM. We identified a cohort with familial cardiomyopathy (FCM) associated with a MYH7 mutation (E848G) and middle-age onset of systolic dysfunction and arrhythmias. hiPSC-CMs from patient affected (FCM-CMs) and non-affected (WT-CMs) individuals were generated from skin fibroblasts. Here we report, for the first time, contractile properties of isolated myofibrils from these cultured hiPSC-CMs for comparison using cultured cells and 3D engineered cardiac tissue (3D-ECT) constructs. Isolated myofibrils were obtained from differentiation day 20 hiPSC-CMs that were replated onto fibronectin-coated nanopatterned cover slides and matured in culture for an additional 60 days to obtain elongated and aligned myofibrils. This procedure produced hiPSC-CMs that were usually > 100+ µm in length. hiPSC- FCM-CMs and WT-CMs were harvested and skinned in a rigor solution containing 1% Triton and contractile properties of single or small bundles of myofibrils were measured in a custom built apparatus with rapid solution switching capabilities. During maximal calcium activation FCM-CM myofibrils produced approximately half the amount of force of WT-CM myofibrils, but preliminary data suggests no differences in the kinetics of force development or relaxation. This compares well with 50 day cardiomyocytes plated on nano-patterned surfaces or seeded into 3D-ECT constructs, where shortening and force (respectively) of FCM-CMs was much less than for WT-CMs, with no difference in calcium transient amplitudes. We speculate this early stage contractile deficit may contribute to disease development and conclude hiPSC-FCM-CMs can be a viable model for mechanical studies of cardiomyopathies in vitro.

Item Type: Conference or workshop item (Lecture)
DOI/Identification number: 10.1016/j.bpj.2014.11.1110
Subjects: Q Science
Q Science > QP Physiology (Living systems)
R Medicine
R Medicine > RB Pathology
Divisions: Divisions > Division of Natural Sciences > Biosciences
Depositing User: A.W. Racca
Date Deposited: 14 Jan 2016 14:59 UTC
Last Modified: 17 Aug 2022 11:00 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/53703 (The current URI for this page, for reference purposes)

University of Kent Author Information

Racca, Alice Ward.

Creator's ORCID:
CReDIT Contributor Roles:
  • Depositors only (login required):

Total unique views for this document in KAR since July 2020. For more details click on the image.